ConductScience.org, home

Paper523338

Inhibition by deprenyl of dopamine uptake in rat striatum: a possible correlation between dopamine uptake and acetylcholine release inhibition.

Harsing LG and 4 others. Pol J Pharmacol Pharm, 1979. Cited by 43 papers, by iCite.

Cite this record

ConductScience Library. Inhibition by deprenyl of dopamine uptake in rat striatum: a possible correlation between dopamine uptake and acetylcholine release inhibition. Papers, record 523338. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/523338

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Inhibition by deprenyl of dopamine uptake in rat striatum: a possible correlation between dopamine uptake and acetylcholine release inhibition.
PubMed
Journal
Pol J Pharmacol Pharm
PubMed
Year
1979
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
43
iCite
Relative citation ratio, by iCite
2.23
iCite
Revised in PubMed
2015-11-19
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Harsing LG JrL G
2Magyar KK
3Tekes KK
4Vizi ESE S
5Knoll JJ

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AcetylcholineMajor topic
Corpus StriatumMajor topic
DopamineMajor topic
PhenethylaminesMajor topic
SelegilineMajor topic
Animals
Clorgyline
Hydroxydopamines
In Vitro Techniques
Neurons
Ouabain
Rats
Stereoisomerism

Source PubMed

Download CSV of topics

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 43 citations.

PMIDTitleJournalYearIn PapersSource
37686140Striking Neurochemical and Behavioral Differences in the Mode of Action of Selegiline and Rasagiline.Int J Mol Sci2023https://conductscience.org/library/papers/37686140PubMed
27480491The significance of selegiline/(-)-deprenyl after 50 years in research and therapy (1965-2015).Mol Psychiatry2016https://conductscience.org/library/papers/27480491PubMed
16787845Restoration and putative protection in Parkinsonism.Neurotox Res2000https://conductscience.org/library/papers/16787845PubMed
11607046
Antiaging compounds: (-)deprenyl (selegeline) and (-)1-(benzofuran-2-yl)-2-propylaminopentane, [(-)BPAP], a selective highly potent enhancer of the impulse propagation mediated release of catecholamine and serotonin in the brain.
CNS Drug Rev2001https://conductscience.org/library/papers/11607046PubMed
7207641Modulation by endogenous dopamine of the release of acetylcholine in the caudate nucleus of the rabbit.Naunyn Schmiedebergs Arch Pharmacol1980https://conductscience.org/library/papers/7207641PubMed
6439273Release of endogenous dopamine from rat isolated striatum: effect of clorgyline and (-)-deprenyl.Br J Pharmacol1984https://conductscience.org/library/papers/6439273PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/523338

GET https://conductscience.org/api/papers/v1/523338/authors